Work

PP01.12: Efficacy and Safety of Taletrecfinib in Pafients with ROS1+ Non-Small Cell Lung Cancer (NSCLC): Updated Safety Analysis From the Phase 2 TRUST-I and TRUST-II Studies

Year: 2026

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2026.104011

Authors: Amanda Herrmann, Jorge J. Nieva, Misako Nagasaka, Geoffrey Liu, Scoft Owen, Xue Meng, Pilar Garrido, Feiwu Ran, Wei Wang, Clara Li, Chris Zhang, Lyudmila Bazhenova

Institutions: University of California San Diego, Moores Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center, University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, University of Toronto, Princess Margaret Cancer Centre, McGill University Health Centre, Shandong Tumor Hospital, Hospital Universitario Ramón y Cajal

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7167283565

Cites:

Cited by:

Related to: 10